Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine

Veterinary Journal

Volumn 177, Issue 3, 2008, Pages 432-435

  Larenza, M Paula ^a   Knobloch, Monika ^a   Landoni, M Fabiana ^b   Levionnois, Olivier L ^a   Kronen, Peter W ^a   Theurillat, Regula ^c   Schatzmann, Urs ^a   Thormann, Wolfgang ^c  

^a VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Capillary electrophoresis; Ketamine enantiomers; Norketamine; Pharmacokinetics; Xylazine

Indexed keywords

ANESTHETIC AGENT; KETA S; KETAMINE; KETASOL; NORKETAMINE; XYLASOL; XYLAZINE;

ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTERIAL GAS; ARTICLE; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ENANTIOMER; ENANTIOSELECTIVITY; HORSE; HYPERCAPNIA; HYPOXEMIA; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RACEMIC MIXTURE; REGRESSION ANALYSIS; SEDATION; STANDING; STEREOCHEMISTRY;

ADRENERGIC ALPHA-AGONISTS; ANESTHESIA, GENERAL; ANESTHETICS, COMBINED; ANESTHETICS, DISSOCIATIVE; ANIMALS; BLOOD GAS ANALYSIS; CROSS-OVER STUDIES; HORSES; KETAMINE; MALE; RANDOM ALLOCATION; STEREOISOMERISM; XYLAZINE;

EID: 45949094385     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.05.005     Document Type: Article

References (10)

1. Doenicke A., Kugler J., Mayer M., Angster R., and Hoffmann P. Ketamine racemate or S-(+)-ketamine and midazolam. The effect on vigilance, efficacy and subjective findings. Der Anaesthesist 41 (1992) 610-618
2. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics. fourth ed (1991), Lea and Febiger, London
3. Ihmsen H., Geisslinger G., and Schuttler J. Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine. Clinical Pharmacology and Therapeutics 70 (2001) 431-438
4. Kharasch E.D., and Labroo R. Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 77 (1992) 1201-1207
5. Knobloch M., Portier C.J., Levionnois O.L., Theurillat R., Thormann W., Spadavecchia C., and Mevissen M. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion. Toxicology and Applied Pharmacology 216 (2006) 373-386
6. Larenza M.P., Landoni M.F., Levionnois O.L., Knobloch M., Kronen P.W., Theurillat R., Schatzmann U., and Thormann W. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies. British Journal of Anaesthesia 98 (2007) 204-212
7. Mama K.R., Wagner A.E., Steffey E.P., Kollias-Baker C., Hellyer P.W., Golden A.E., and Brevard L.F. Evaluation of xylazine and ketamine for total intravenous anesthesia in horses. American Journal of Veterinary Research 66 (2005) 1002-1007
8. Schwartz G. Estimating the dimension of a model. Annals of Statistics 6 (1978) 461-464
9. Theurillat R., Knobloch M., Levionnois O., Larenza P., Mevissen M., and Thormann W. Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis. Electrophoresis 26 (2005) 3942-3951
10. Yamaoka K., Nakagawa T., and Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 6 (1978) 65-175